Olipudase Alfa: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Olipudase Alfa. Educational only — not medical advice.
Labeled uses
XENPOZYME is indicated for treatment of non–central nervous system manifestations of acid sphingomyelinase deficiency (ASMD) in adult and pediatric patients.
Source: FDA labeling via NIH DailyMed (set 01a910ee…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.